Landscapes / Companies
R-Pharm not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials · 11 in all
Trials
4 active
18 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
R-Pharm International |
Approved in Russia | 9 Apr 2027Phase 2/3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 9 Apr 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Lung Diseases, Interstitial, Juvenile Idiopathic Arthritis and 2 more | ||||
| Open drug page | |||||
Receptor molecules, native or modified |
R-Pharm International |
Phase 3 | 14 Dec 2027Phase 3 trial completes | ||
| How it works | A decoy protein that soaks up a signal molecule before it can reach the body's cells | ||||
| Next date | 14 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Familial Mediterranean Fever, FMF and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Locally Advanced Breast Cancer, Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Metastatic Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Multiple Sclerosis | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021